New Platform Includes both a Device and App that Leverages Gaming Technology and Therapeutic Methods So Users Can Improve Outcomes Faster

CalmiGo, developer of the first and only mental health platform that provides immediate relief and long-term care to users suffering from anxiety, PTSD, and panic attacks, announces today the launch of their next-generation healthcare platform, CalmiGo Plus, designed to manage anxiety within minutes and track data insights. The new platform includes both the award-winning CalmiGo device and new app that leverages gaming technology to improve outcomes faster and effectively manage their anxiety each day. Additionally, with CalmiGo Plus users and clinicians can monitor their anxiety levels and track their progress through the app.

The habit-forming game in the app was developed from principles in psychology to aid users in the healing process. The app also creates individual treatment plans and provides rewards to further encourage users on their journey of managing their anxiety. The app is easy-to-use and intuitive so that anyone - of any age or background - can seamlessly benefit from it. CalmiGo developed the app as an optional add-on for users with various preferences - some will prefer the gaming features while others can use the progress monitoring offering, a timer with relaxing music, or just use the app every two weeks just to sync the device. This ensures that every user, regardless of their preference, can benefit from the app and expedite their healing. The CalmiGo app also enables an accessibility mode for screen readers to make access available to anyone.

“Oftentimes anxiety and panic attacks can cast a heavy burden on individuals and as a consequence they avoid situations and places and live in fear of the next attack,” says Adi Wallach, CEO of CalmiGo. “CalmiGo is designed to empower users with a device so that they can go anywhere knowing that they have relief in their pocket at all times and now the new app creates the habit of regular use effortlessly.”

The CalmiGo device is a scientifically-proven device that reduces stress hormone levels and provides immediate drug-free relief, enabling users to step out of the vicious anxiety cycle and regain control of their life - no matter where they are located. The device is a unique portable exhaler developed with patented technology that combines sensors and machine learning to regulate breathing patterns. It learns each user’s individual breathing patterns in real time and provides guidance and feedback to help extend the length of exhalation between breathing cycles. Gradually extended exhalation activates the parasympathetic system, which counteracts the “fight or flight” response triggered by the sympathetic nervous system in high-stress situations.

To date, over 100,000 users have benefited from CalmiGo. The company recently created availability to more users through payment plans, FSA/HSA plans, and key partnerships. Additionally, CalmiGo collaborated with healthcare providers, insurance plans, and healthcare institutions and clinics that subsidize the device for their patients, including a unique partnership with the U.S. Department of Veterans Affairs (VA).

To access the app, visit the app store or Google play.

About CalmiGo

CalmiGo is a mental health startup with patented technology that combines sensors and machine learning to calm the mind and body in minutes. It focuses on empowering people suffering from anxiety, panic attacks, and PTSD so that they can easily manage their anxiety anywhere, and in any situation. The company is headquartered in New York, NY. To learn more, visit CalmiGo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241007036220/en/